# Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)

> **NCT05403346** · — · TERMINATED · sponsor: **Lumos Diagnostics** · enrollment: 45 (actual)

## Conditions studied

- SARS-CoV-2
- Covid19

## Interventions

- **DEVICE:** CoviDx™ Covid-19 Antigen Self-Test

## Key facts

- **NCT ID:** NCT05403346
- **Lead sponsor:** Lumos Diagnostics
- **Sponsor class:** INDUSTRY
- **Phase:** —
- **Study type:** OBSERVATIONAL
- **Status:** TERMINATED
- **Start date:** 2022-05-17
- **Primary completion:** 2022-08-01
- **Final completion:** 2022-10-31
- **Target enrollment:** 45 (ACTUAL)
- **Why stopped:** Study was terminated due to the difficulty to enrol patients
- **Last updated:** 2022-11-16

## Collaborators

- [object Object]

## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT05403346

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT05403346, "Clinical Evaluation of a COVID-19 Antigen Self-Test (CoviDx™)". Retrieved via AI Analytics 2026-05-28 from https://api.ai-analytics.org/clinical/NCT05403346. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*